Hacker Newsnew | past | comments | ask | show | jobs | submitlogin

His point was more along the lines of it being poorly designed.

Evolution isn't going to nicely separate functionality into clean, single-purpose biochemical pathways.

It's going to overload something that it already has to support a new feature, leading to a rat's nest of intertwined effects.

The hard part in drug development isn't affecting your target: that's pretty easy to guarantee with modern tools. It's finding out that that target also governs 10 other, completely unrelated bodily functions.



> It's going to overload something that it already has to support a new feature,

Some companies in the valley just call that Wednesday.=)


Absolutely, which gives me a chuckle when people trivialize biology, but run screaming from a (gasp!) 20 year old legacy codebase.




Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact

Search: